Literature DB >> 6234326

Hypersensitivity to antigen derived from brain tissue in patients with Huntington's disease and in individuals at risk.

R S Walls, A Ruwoldt.   

Abstract

The hypothesis that an immune response is directed to components of brain tissue in Huntington's disease (HD) was examined. 27 patients with HD, 21 children of affected parents who showed no signs of disease, 6 spouses of HD patients, and 40 patients with other neurologic diseases were investigated. Leukocyte migration inhibition to antigens prepared from brain tissue was demonstrated in 26 HD patients and in 9 children. None of the six spouses reacted. 13 patients with other neurologic conditions (including 60% of patients after cerebrovascular accidents) reacted to rat brain extract. Fractionation of brain tissue indicated that the material responsible for reactions in these patients differed from that in HD. The material that elicited hypersensitivity in HD was not species specific, since it was found in rat, calf, human, and rabbit brain. It was not present in rat kidney, liver, or heart. Preliminary characterization showed that the material was protein in nature, contained sugar and lipid, and was heat labile. The finding of hypersensitivity in about half the unaffected children of HD parents suggests that it may precede the clinical onset of disease and serve as a marker for the gene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234326      PMCID: PMC425197          DOI: 10.1172/JCI111397

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Characterization of brain proteins reacting in vitro with anti-neuronal antibodies in patients with Huntington's disease.

Authors:  G Husby; E Wedege; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1978-10

2.  Evaluation of the leucocyte migration test as a measure of delayed hypersensitivty in man. Suppression of migration inhibition by puromycin.

Authors:  C G Mitchell; M G Smith; P L Golding; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1972-08       Impact factor: 4.330

3.  Huntington's disease: genetically programmed cell death in the human central nervous system.

Authors:  J B Martin
Journal:  Nature       Date:  1982-09-16       Impact factor: 49.962

4.  Huntington's disease and leucocyte adherence inhibition. (LAI).

Authors:  S I Hardiwidjaja; A Morgan; G W Ellison; L W Myers; W G Pierce; D S Barkley
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

5.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

6.  Cellular immune responses in Huntington's disease (H.D.). Detection of H.D. and multiple sclerosis (M.S.) brain antigenicity by H.D. but not M.S. lymphocytes.

Authors:  D S Barkley; S I Hardiwidjaja; J H Menkes; G W Ellison; L W Myers
Journal:  Cell Immunol       Date:  1977-08       Impact factor: 4.868

7.  Human lymphocyte migration as a parameter of hypersensitivity.

Authors:  M Soborg; G Bendixen
Journal:  Acta Med Scand       Date:  1967-02

8.  The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system.

Authors:  F Michetti; A Massaro; G Russo; G Rigon
Journal:  J Neurol Sci       Date:  1980-01       Impact factor: 3.181

9.  Genetic approaches to the nosology of muscular disease: myotonias and similar diseases.

Authors:  P E Becker
Journal:  Birth Defects Orig Artic Ser       Date:  1971-02

10.  Antibodies to human caudate nucleus neurons in Huntington's chorea.

Authors:  G Husby; L Li; L E Davis; E Wedege; E Kokmen; R C Williams
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  2 in total

1.  The interaction of a Huntington disease factor with receptors for the neurotoxin kainic acid.

Authors:  P R Dodd; W E Watson; M M Morrison; G A Johnston; A I Smith; A Ruwoldt; R S Walls
Journal:  Metab Brain Dis       Date:  1991-12       Impact factor: 3.584

2.  Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins.

Authors:  H J Willison; G Paterson; J Veitch; G Inglis; S C Barnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.